Filling the need for trusted information on national health issues…

Trending on kff Open Enrollment Medicare Part D Medicaid Expansion

Kaiser Daily Global Health Policy ReportPrivate Sector Involvement Search Results « » The Henry J. Kaiser Family Foundation

Private Sector Involvement

  • your selections
Clear Search

Filter Results



  • results
2 Clinical Trials Of Experimental Ebola Vaccines Begin In Europe, Africa

Reuters: Two new trials of Ebola vaccines begin in Europe and Africa “Two new Ebola vaccine trials began on Wednesday with volunteers in Britain, France, and Senegal getting ‘prime-boost’ immunizations developed by Bavarian Nordic, GlaxoSmithKline, and Johnson & Johnson…” (Kelland, 7/15).

U.S. Chamber Of Commerce Lobbied Against Anti-Smoking Laws In LMICs, New Report Says

The Hill: Report: Chamber fought anti-smoking laws in low-income countries “The U.S. Chamber of Commerce targeted low- and middle-income countries in lobbying against anti-smoking regulations, according to a report health and safety groups unveiled Thursday. The report, ‘Blowing Smoke for Big Tobacco,’ from nine groups including the Campaign for Tobacco-Free…

Sanofi Hopes To Improve Public Health, Profits With New Dengue Vaccine

Financial Times: Sanofi confident dengue drug will benefit patients and investors “…[D]rugs group Sanofi has produced the world’s first vaccine for the mosquito-borne viral disease [dengue], which it expects to launch by the end of this year. While Sanofi is championing the potential public health benefits of the vaccine, the…

For Businesses, Social, Economic Goals Must Overlap To Achieve Sustainable Development

Forbes: How Do We Get Businesses Working Towards the Sustainable Development Goals? Bhaskar Chakravorti, senior associate dean of international business and finance at the Fletcher School at Tufts University “…With the majority of [future economic] growth expected from the developing world, self-interest may be the most compelling reason for businesses…

U.N.-Backed Diagnostics Access Initiative Announces Lower Price Of Infant HIV Testing Technologies In Partnership With Roche

U.N. News Centre: U.N.-backed initiative announces deal to sharply lower price of HIV early infant diagnosis “A dramatic 35 percent reduction in the price for HIV early infant diagnostic technologies [Monday was] announced by the United Nations-backed Diagnostics Access Initiative, in partnership with Roche Diagnostics. … The new access price…

Pharmaceutical Companies Can Contribute To Improving Maternal, Reproductive Health

The Guardian: Are pharma giants living up to big promises on development? Damiano de Felice, strategic adviser to the CEO of the Access to Medicine Foundation, and Jayasree K. Iyer, the foundation’s chief scientific officer “…The [Access to Medicine] Foundation’s latest report maps how the [pharmaceutical] companies it tracks are…

Focus On Better Management, Deployment Of Existing, New Drugs Instead Of Cost

The Hill: New approach needed in fight against deadly diseases Roger Bate, scholar at the American Enterprise Institute “…Constant focus on drug pricing and criticism of lack of access can discourage developers from investing in new treatments. … TB and malaria are being combated in poor countries, but drug resistance…